Accepted for Publication: May 24, 2012.
Published Online: September 17, 2012. doi:10.1001/archinternmed.2012.3747
Author Contributions: Dr Tobias had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Tobias, Hu, and Zhang. Acquisition of data: Hu. Analysis and interpretation of data: Tobias, Chavarro, Rosner, and Mozaffarian. Drafting of the manuscript: Tobias and Zhang. Critical revision of the manuscript for important intellectual content: Hu, Chavarro, Rosner, Mozaffarian, and Zhang. Statistical analysis: Tobias, Chavarro, and Rosner. Administrative, technical, and material support: Tobias. Study supervision: Hu, Mozaffarian, and Zhang.
Financial Disclosure: Dr Mozaffarian has received research grants from GlaxoSmithKline, Sigma Tau, Pronova, and the National Institutes of Health for an investigator-initiated, not-for-profit clinical trial of fish oil supplements and postsurgical complications; ad hoc travel reimbursement and/or honoraria for research presentations on diet and cardiometabolic diseases from the International Life Sciences Institute, Aramark, Unilever, Bunge, SPRIM, and Nutrition Impact; ad hoc consulting fees from Foodminds and McKinsey Health Systems Institute; and royalties from UpToDate for an online chapter on fish oil. In addition, Harvard University has filed a provisional patent application that has been assigned to Harvard University, listing Dr Mozaffarian as a coinventor, to the US Patent and Trademark Office for use of trans-palmitoleic acid to prevent and treat insulin resistance, T2DM, and related conditions.
Funding/Support: This study was supported by grants DK58845 and P30 DK46200-18 from the National Institute of Diabetes and Digestive and Kidney Diseases; by grant CA50385 from the National Cancer Institute; and by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (Dr Zhang).